Zyprexa

Eli Lilly settles Zyprexa inquiries

Drugmaker Eli Lilly & Co. cleared another legal cloud hanging over its top-selling drug Zyprexa when it announced a $62 million settlement Tuesday, but several other storms are still brewing for the antipsychotic medication.

State settles lawsuit over lack of warnings on dangerous drug

Just days before its case would have gone to a jury, the state settled a lawsuit against Eli Lilly over the drug Zyprexa for $15 million in a deal that disappointed lawyers fighting in court for the state.

Eli Lilly settles state lawsuit for $15 million

Eli Lilly has agreed to pay $15 million to the state of Alaska to settle a lawsuit claiming that the pharmaceutical company's schizophrenia drug Zyprexa caused patients to develop diabetes.

Defense opens in Zyprexa trial

In an Alaska courtroom, drug maker Eli Lilly is finally getting to defend itself against accusations that it failed to warn doctors and patients of health problems from its best-seller, Zyprexa.

Japan made Zyprexa labels reflect risk to diabetics

When health officials in Japan learned of serious health complications from the schizophrenia drug Zyprexa back in 2002, they forced the drug maker to put a strong warning on its label: Do not give to patients with diabetes.

API patients on Zyprexa got diabetes, official says

API patients on Zyprexa got diabetes, official says

Patients taking the anti-psychotic drug Zyprexa needlessly developed diabetes because doctors didn't have all the information about risks, the medical director of Alaska's only public mental hospital said in court Wednesday.

Juror collapses in Zyprexa trial

The trial in the state's suit against pharmaceutical giant Eli Lilly in Anchorage Superior Court was delayed this morning when a juror collapsed just as proceedings got under way.

State claims Lilly tried to blur Zyprexa-diabetes link

Back in 2002, Eli Lilly and Co. came up with a $10 million effort to ramp up sales of its schizophrenia medicine, Zyprexa. They called it Project "BAD."

State claims drug maker hid data

Drug maker Eli Lilly knew from the start that its schizophrenia drug Zyprexa was linked to health problems in patients but hid that information because it wanted a big moneymaker, a lawyer for the state told jurors in Anchorage Superior Court on Wednesday.

PDF: Eli Lilly opening statement slides

Millions of dollars at stake in Zyprexa trial

Millions of dollars at stake in Zyprexa trial

Jury selection for one of the biggest civil trials ever in Alaska is now under way in Anchorage Superior Court with tens of millions of dollars riding on the verdict.

Anchorage attorney ordered to return documents on drug (2/14/2007)

A federal judge in New York on Tuesday ruled that Anchorage attorney Jim Gottstein, a New York Times reporter and a doctor conspired to steal documents about the controversial drug Zyprexa and then publicize what the papers said.

State has sued Lilly over drug (2/13/20007)

Zyprexa, a medication for schizophrenia and bipolar disorder, is Eli Lilly's best-seller. But the company has been embroiled in controversy over it for years.

Anchorage attorney battles drug giant (2/13/2007)

Anchorage lawyer Jim Gottstein has emerged as a player in a national controversy over the psychiatric medication Zyprexa, which is Eli Lilly's best-selling drug.